Drug Database
Back to search

United States· US:68727-712_846f5d71-faab-42a5-85d6-d83626b7bf3c

ZEPZELCA

A lurbinectedin product containing lurbinectedin, registered in United States by Jazz Pharmaceuticals, Inc.. The same ATC class is registered in 8 of our 19 countries.

ATC L01XX69US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedZEPZELCAATCL01XX69REGISTER NO.US:68727-712_846f5d71…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lurbinectedinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lurbinectedin is registered in 8 of 19 countries.

Countries holding a registration under ATC L01XX69 (lurbinectedin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 6 of them publish a price we can compare per daily dose
Search lurbinectedin products by name

Lurbinectedin · ATC L01XX69

8 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
LURBINECTEDIN
Manufacturer
Jazz Pharmaceuticals, Inc.
Country
United States (US)
ATC code
L01XX69
ATC class
Lurbinectedin
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    6872771201
    8 mL in 1 VIAL, SINGLE-DOSE (68727-712-01)
  • ndc11
    68727-712-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

203 interactions on record for lurbinectedin.

Graded by severity as the source publishes them — 60 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lurbinectedin against other medicinesHow interaction checks work

Lurbinectedin · interactions on record

203 records

  • 60 severe
  • 142 moderate
  • 1 minor

Most severe, free to view

  • AprepitantA04AD12severe
  • DexamethasoneH02AB02severe
  • KetoconazoleH02CA03severe
  • ChloramphenicolJ01BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lurbinectedin in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lurbinectedin products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Zepzelca
  • Liechtenstein · Zepzelca
  • Norway · Zepzelca

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8d482b80-7f75-4d25-8c2a-ad0af833027a
GET /v1/drugs/8d482b80-7f75-4d25-8c2a-ad0af833027a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": ".5",
  "substance": "LURBINECTEDIN",
  "productndc": "68727-712",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "NDA213702",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about lurbinectedin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console